Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in Bandung
Diabetes Mellitus, Type 2
About this trial
This is an interventional supportive care trial for Diabetes Mellitus, Type 2
Eligibility Criteria
Inclusion Criteria: Subjects are in the diabetes type 2 status (based on Perkeni standard) HbA1c is ≥6.5% Aged 18 - 60 years old Have compatible smartphone (minimum android 8 or iOS 13) and internet connection Receiving regular diabetes treatment Giving consent and commitment to participate in the study until finish Located in Bandung Area within the treatment period (up to 3 month after receiving the treatment) Subject is determined to be able to complete daily physical activities. Exclusion Criteria: Pregnant (based on test pack) Participation in other weight loss program Use of other tracking application Having any abnormalities that affecting blood erythrocyte age defined by laboratory examination Have other severe diabetic complications that prevent subjects from participating in the prescribed program (Such as stroke, cardiac diseases (CHF stage III-IV), COPD or asthma with acute exacerbation and other respiratory diseases, peripheral artery disease, CKD stage 3-5) and other severe diseases that by the investigator's judgment, could not participate in this study
Sites / Locations
- Immanuel HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Group I (Treatment)
Group II (Control)
Regular diabetes treatment with additional Medwell application and wearable device.
Regular diabetes treatment only with a diary card to record daily activities manually.